il-1

  1. SNT Gatchaman

    Plasma proteomic profile reveals persistent immune activation in post-acute sequelae of SARS-CoV-2 infection, 2026, Fineschi, Bergquist+

    Plasma proteomic profile reveals persistent immune activation in post-acute sequelae of SARS-CoV-2 infection Plasma proteomic profiling of 92 individuals with Post-Acute Sequelae of SARS-CoV-2 infection (PASC), assessed a mean of 34 months after acute infection, revealed a distinct...
  2. SNT Gatchaman

    Extracellular Vesicle-Delivered tRF-His-GTG-1 Reprograms Neutrophil Lipophagy and Triggers Inflammation in COVID-19, 2026, Liao et al.

    Extracellular Vesicle-Delivered tRF-His-GTG-1 Reprograms Neutrophil Lipophagy and Triggers Inflammation in COVID-19 Immunometabolism and neutrophil extracellular traps (NETs) play pivotal roles in the pathogenesis of coronavirus disease 2019 (COVID-19) and its postacute sequelae. However, the...
  3. SNT Gatchaman

    Long-term immune and epigenetic dysregulation following COVID-19, 2026, Sidiropoulou et al.

    Long-term immune and epigenetic dysregulation following COVID-19 Post-Acute COVID-19 syndrome (PACS) is heterogeneous in phenotype and functional state. This prospective, observational study studied adults six months after acute COVID-19. We defined clinical phenotypes and profiled plasma...
Back
Top Bottom